Shaaltiel Yoseph Insider Trades

Insider Trading History

Track insider trading activity for Shaaltiel Yoseph. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $1.41M 700,000 shares
Last Trade
Sep 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.57M 700,000 shares
$5.10
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $1.18M 585,916 shares
Last Trade
Sep 15, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$731k 122,162 shares
$5.98
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $0 0 shares
Last Trade
Sep 15, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$731k 122,162 shares
$5.98
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $553k 275,000 shares
Last Trade
Mar 23, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.73M 275,000 shares
$17.20
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $422k 210,000 shares
Last Trade
Jul 16, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12M 210,000 shares
$57.20
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $932k 463,754 shares
Last Trade
May 02, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
$21M 300,000 shares
$70.10
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $1.54M 763,754 shares
Last Trade
Aug 06, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$321k 4,619 shares
$69.60
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $1.54M 768,373 shares
Last Trade
Aug 05, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.36M 48,408 shares
$69.40
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $1.64M 816,781 shares
Last Trade
Jun 21, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.65M 52,973 shares
$68.90
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $1.75M 869,754 shares
Last Trade
Apr 29, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$886k 12,691 shares
$69.80
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $1.77M 882,445 shares
Last Trade
Apr 14, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$91.6k 1,309 shares
$70.00
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $1.78M 883,754 shares
Last Trade
Mar 25, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.49M 50,000 shares
$69.70
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $1.88M 933,754 shares
Last Trade
Mar 24, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.3M 202,700 shares
$70.40
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $2.28M 1,136,454 shares
Last Trade
Mar 23, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$8.86M 127,300 shares
$69.60
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $291k 145,000 shares
Last Trade
Feb 25, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.96M 145,000 shares
$68.70
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $2.54M 1,263,754 shares
Last Trade
Oct 19, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.09M 43,120 shares
$94.80
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $2.63M 1,306,874 shares
Last Trade
Oct 16, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.37M 25,680 shares
$92.10
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $2.68M 1,332,554 shares
Last Trade
Oct 15, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.92M 31,200 shares
$93.70
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $2.78M 1,383,754 shares
Last Trade
Jul 06, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.88M 100,000 shares
$48.80
$2.01
Protalix BioTherapeutics
Protalix BioTherapeutics PLX
Executive Vp, R&d
Holding Value $2.94M 1,463,754 shares
Last Trade
May 14, 2009 Sale (Open Market)Shares sold on the open market or in a private sale.
$416k 10,000 shares
$41.60
$2.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up